Building the Case for Insulin-Like Growth Factor Receptor-I Involvement in Thyroid-Associated Ophthalmopathy.
about
Rebuttal to Smith and Janssen (Thyroid 2017;27:746-747. DOI: 10.1089/thy.2017.0281).TSHR/IGF-1R Cross-Talk, Not IGF-1R Stimulating Antibodies, Mediates Graves' Ophthalmopathy Pathogenesis.CD34- Orbital Fibroblasts From Patients With Thyroid-Associated Ophthalmopathy Modulate TNF-α Expression in CD34+ Fibroblasts and Fibrocytes.Thyroid-Associated Orbitopathy and Biomarkers: Where We Are and What We Can Hope for the Future.
P2860
Building the Case for Insulin-Like Growth Factor Receptor-I Involvement in Thyroid-Associated Ophthalmopathy.
description
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
name
Building the Case for Insulin- ...... oid-Associated Ophthalmopathy.
@en
Building the Case for Insulin- ...... oid-Associated Ophthalmopathy.
@nl
type
label
Building the Case for Insulin- ...... oid-Associated Ophthalmopathy.
@en
Building the Case for Insulin- ...... oid-Associated Ophthalmopathy.
@nl
prefLabel
Building the Case for Insulin- ...... oid-Associated Ophthalmopathy.
@en
Building the Case for Insulin- ...... oid-Associated Ophthalmopathy.
@nl
P2860
P356
P1476
Building the Case for Insulin- ...... roid-Associated Ophthalmopathy
@en
P2093
Joseph A M J L Janssen
Terry J Smith
P2860
P356
10.3389/FENDO.2016.00167
P577
2016-01-01T00:00:00Z